19-53809587-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_144687.4(NLRP12):​c.2072T>A​(p.Leu691Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 18/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L691P) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

NLRP12
NM_144687.4 missense, splice_region

Scores

16
Splicing: ADA: 0.00001883
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.96

Publications

0 publications found
Variant links:
Genes affected
NLRP12 (HGNC:22938): (NLR family pyrin domain containing 12) This gene encodes a member of the CATERPILLER family of cytoplasmic proteins. The encoded protein, which contains an N-terminal pyrin domain, a NACHT domain, a NACHT-associated domain, and a C-terminus leucine-rich repeat region, functions as an attenuating factor of inflammation by suppressing inflammatory responses in activated monocytes. Mutations in this gene cause familial cold autoinflammatory syndrome type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
NLRP12 Gene-Disease associations (from GenCC):
  • familial cold autoinflammatory syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.098255694).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_144687.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP12
NM_144687.4
MANE Select
c.2072T>Ap.Leu691Gln
missense splice_region
Exon 3 of 10NP_653288.1
NLRP12
NM_001277126.2
c.2072T>Ap.Leu691His
missense splice_region
Exon 3 of 10NP_001264055.1
NLRP12
NM_001277129.1
c.2072T>Ap.Leu691Gln
missense splice_region
Exon 3 of 9NP_001264058.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP12
ENST00000324134.11
TSL:1 MANE Select
c.2072T>Ap.Leu691Gln
missense splice_region
Exon 3 of 10ENSP00000319377.6
NLRP12
ENST00000391773.8
TSL:1
c.2072T>Ap.Leu691His
missense splice_region
Exon 3 of 10ENSP00000375653.1
NLRP12
ENST00000345770.9
TSL:1
c.2072T>Ap.Leu691His
missense splice_region
Exon 3 of 9ENSP00000341428.5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
40
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Familial cold autoinflammatory syndrome 2 Uncertain:1
Sep 01, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with NLRP12-related conditions. This sequence change replaces leucine, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 691 of the NLRP12 protein (p.Leu691Gln).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.64
DANN
Benign
0.75
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.28
T
M_CAP
Benign
0.0097
T
MetaRNN
Benign
0.098
T
MetaSVM
Benign
-0.87
T
PhyloP100
-3.0
PrimateAI
Benign
0.40
T
PROVEAN
Benign
1.4
N
REVEL
Benign
0.12
Sift
Benign
0.38
T
Sift4G
Benign
0.53
T
Vest4
0.15
MutPred
0.54
Loss of stability (P = 0.0148)
MVP
0.48
ClinPred
0.072
T
GERP RS
-2.3
Varity_R
0.070
gMVP
0.26
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000019
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760012636; hg19: chr19-54312841; API